The Principles of Clinical Cytogenetics - Extra Materials - Springer

Genetic Counseling 557
3. Walker, A.P. (1998) The practice of genetic counseling. In A Guide to Genetic Counseling (Baker, D.L., Schuette, J.L.,
and Uhlmann, W.R., eds.), Wiley–Liss, New York, pp. 1–20.
4. Heimler, A. (1997) An oral history of the National Society of Genetic Counselors. J. Genet. Counsel. 6(3), 315–336.
5. Bennett, R.L., Steinhaus, K.A., Uhrich, S.B., et al. (1995) Recommendations for standardized human pedigree nomenclature.
J. Genet. Counsel. 4, 267–279.
6. Resta, R.G. (1993) The crane’s foot: the rise of the pedigree in human genetics. J. Genet. Counsel. 2(4), 235–260.
7. American College of Obstetricians and Gynecologists (1995) Fragile X syndrome. ACOG Committee Opinion No.
161. American College of Obstetricians and Gynecologists.
8. McIntosh, N., Gane, L.W., McConkie-Rosell, A., and Bennett, R.L. (2000) Genetic Counseling for Fragile X syndrome:
recommendations of the National Society of Genetic Counselors. J. Genet. Counsel. 9(4), 303–325.
9. American College of Medical Genetics (1994) Fragile X syndrome: diagnostic and carrier testing. ACMG Policy Statement.
American College of Medical Genetics.
10. Nussbaum, R.L., McInnes, R.R., and Willard, H.F. (2001) Thompson & Thompson Genetics in Medicine, 6th ed. WB
Saunders, Philadelphia.
11. Goyette, R.E. (1997) Hematology: A Comprehensive Guide to the Diagnosis & Treatment of Blood Disorders. Practice
Management Information Corporation, Los Angeles.
12. Bennett, R.L., Motulsky, A.G., Bittles, A., et al. (2002) Genetic counseling and screening of consanguineous couples
and their offspring: recommendations of the National Society of Genetic Counselors. J. Genet. Counsel. 11(2), 97–119.
13. Hook, E.B. (1981) Rates of chromosomal abnormalities at different maternal ages. Obstet. Gynaecol. 58(3), 282–285.
14. American College of Medical Genetics (1994) Multiple marker screening in women 35 and older. ACMG Policy Statement.
American College of Medical Genetics.
15. Gardner, R.J.M. and Sutherland, G.R. (2004) Chromosome Abnormalities and Genetic Counseling, 3rd ed. Oxford
University Press, New York.
16. American Society for Reproductive Medicine and Society for Reproductive Endocrinology and Infertility (2002) Practical
genetic evaluation and counseling for infertile couples. ASRM and SREI Practice Committee Report. American
Society for Reproductive Medicine and Society for Reproductive Endocrinology and Infertility.
17. Cooley, W.C. and Graham, J.M. (1991) Common syndromes and management issues for primary care physicians:
Down syndrome—an update and review for the primary pediatrician. Clin. Pediatr. 30(4), 233–253.
18. Jones, K.L (1997) Smith’s Recognizable Patterns of Human Malformation, 5th ed. WB Saunders, Philadelphia.
19. Rossi, E., Piccini, F., Zollino, M., et al. (2001) Cryptic telomeric rearrangements in subjects with mental retardation
associated with dysmorphism and congenital malformations. J. Med. Genet. 38, 417–420.
20. Knight, S., Regan, R., Nicod, A., et al. (1999) Subtle chromosomal rearrangements in children with unexplained mental
retardation. Lancet 354, 1676–1681.
21. de Vries, B.B.A., White, S.M., Knight, S.J., et al. (2001) Clinical studies on submicroscopic subtelomeric rearrangements:
a checklist. J. Med. Genet. 38(3), 145–150.
22. Linden, M.G., Bender, B.G., and Robinson, A. (1996) Intrauterine diagnosis of sex chromosome aneuploidy. Obstet.
Gynecol. 87(3), 468–475.
23. Robinson, W.P., Barrett, I.J., Bernard, L., et al. (1997) Meiotic origin of trisomy in confined placental mosaicism is
correlated with presence of fetal uniparental disomy, high levels of trisomy in trophoblast, and increased risk of fetal
intrauterine growth restriction. Am. J. Hum. Genet. 60, 917–927.
24. Wolstenholme, J., Rooney, D.E., and Davison, E.V. (1994) Confined placental mosaicism, IUGR, and adverse pregnancy
outcome: a controlled retrospective U.K. collaborative survey. Prenat. Diagn. 14, 345–361.
25. Divane, A., Carter, N.P., Spathas, D.H., and Ferguson-Smith, M.A. (1994) Rapid prenatal diagnosis of aneuploidy from
uncultured amniotic fluid cells using five-colour fluorescence in situ hybridization. Prenat. Diagn. 14, 1061–1069.
26. Philip, J., Bryndorf, T., and Christensen, B. (1994) Prenatal aneuploidy detection in interphase cells by fluorescence in
situ hybridization (FISH). Prenat. Diagn. 14, 1203–1215.
27. Witters, I., Devriendt, K., Legius, E., et al. (2002) Rapid prenatal diagnosis of trisomy 21 in 5049 consecutive uncultured
amniotic fluid samples by fluorescence in situ hybridisation (FISH). Prenat. Diagn. 22, 29–33.
28. American College of Medical Genetics. (2000) Prenatal interphase fluorescence in situ hybridization (FISH) policy
statement. Genet. Med. 2, 356–361.
29. Krantz, D.A., Hallahan, T.W., Orlandi, F., Buchanan, P., Larsen, J.W., and Macri, J.N. (2000) First-trimester Down
syndrome screening using dried blood biochemistry and nuchal translucency. Obstet. Gynecol. 96(2), 207–213.
30. Spencer, K. (2001) Age related detection and false positive rates when screening for Down’s syndrome in the first
trimester using fetal nuchal translucency and maternal serum free βhCG and PAPP-A. Br. J. Obstet., Gynaecol. 108,
1043–1046.
31. Orlandi, F., Damiani, G., Hallahan, T.W., Krantz, D.A., and Macri, J.N. (1997) First-trimester screening for fetal
aneuploidy: biochemistry and nuchal translucency. Ultrasound Obstet. Gynecol. 10, 381–386.
32. Senat, M.V., De Keersmaecker, B., Audibert, F., Montcharmont, G., Frydman, R., and Ville, Y. (2002) Pregnancy
outcome in fetuses with increased nuchal translucency and normal karyotype. Prenat. Diagn. 22, 345–349.